| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.017 | 0.9 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |